Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Chronic Urticaria Or Hives Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Chronic Urticaria Or Hives Drugmarket, defines the market attractiveness level of Chronic Urticaria Or Hives Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Chronic Urticaria Or Hives Drug industry, describes the types of Chronic Urticaria Or Hives Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chronic Urticaria Or Hives Drug market and the development prospects and opportunities of Chronic Urticaria Or Hives Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chronic Urticaria Or Hives Drug market in Chapter 13.
By Player:
Biofrontera AG
GlaxoSmithKline Plc
Panacea Biotec Limited
Novartis AG
AstraZeneca Plc
Mabtech Limited
Faes Farma, SA
By Type:
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
By End-User:
Clinic
Hospital
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Chronic Urticaria Or Hives Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Chronic Urticaria Or Hives Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Chronic Urticaria Or Hives Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Chronic Urticaria Or Hives Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Chronic Urticaria Or Hives Drug Market Analysis and Outlook to 2022
-
7.1 Global Chronic Urticaria Or Hives Drug Consumption (2017-2022)
-
7.2 United States Chronic Urticaria Or Hives Drug Consumption (2017-2022)
-
7.3 Europe Chronic Urticaria Or Hives Drug Consumption (2017-2022)
-
7.4 China Chronic Urticaria Or Hives Drug Consumption (2017-2022)
-
7.5 Japan Chronic Urticaria Or Hives Drug Consumption (2017-2022)
-
7.6 India Chronic Urticaria Or Hives Drug Consumption (2017-2022)
-
7.7 South Korea Chronic Urticaria Or Hives Drug Consumption (2017-2022)
8 Region and Country-wise Chronic Urticaria Or Hives Drug Market Analysis and Outlook to 2028
-
8.1 Global Chronic Urticaria Or Hives Drug Consumption Forecast (2022-2028)
-
8.2 United States Chronic Urticaria Or Hives Drug Consumption Forecast (2022-2028)
-
8.3 Europe Chronic Urticaria Or Hives Drug Consumption Forecast (2022-2028)
-
8.4 China Chronic Urticaria Or Hives Drug Consumption Forecast (2022-2028)
-
8.5 Japan Chronic Urticaria Or Hives Drug Consumption Forecast (2022-2028)
-
8.6 India Chronic Urticaria Or Hives Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Chronic Urticaria Or Hives Drug Consumption Forecast (2022-2028)
9 Global Chronic Urticaria Or Hives Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Chronic Urticaria Or Hives Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global GDC-0853 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global GSK-2646264 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global BF-Derm-1 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Bilastine Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Chronic Urticaria Or Hives Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Chronic Urticaria Or Hives Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Chronic Urticaria Or Hives Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global GDC-0853 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global GSK-2646264 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global BF-Derm-1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Bilastine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Chronic Urticaria Or Hives Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Chronic Urticaria Or Hives Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Chronic Urticaria Or Hives Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Chronic Urticaria Or Hives Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Chronic Urticaria Or Hives Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Chronic Urticaria Or Hives Drug Market Competitive Analysis
-
14.1 Biofrontera AG
-
14.1.1 Biofrontera AG Company Details
-
14.1.2 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Biofrontera AG Chronic Urticaria Or Hives Drug Product and Service
-
14.2 GlaxoSmithKline Plc
-
14.2.1 GlaxoSmithKline Plc Company Details
-
14.2.2 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product and Service
-
14.3 Panacea Biotec Limited
-
14.3.1 Panacea Biotec Limited Company Details
-
14.3.2 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product and Service
-
14.4 Novartis AG
-
14.4.1 Novartis AG Company Details
-
14.4.2 Novartis AG Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis AG Chronic Urticaria Or Hives Drug Product and Service
-
14.5 AstraZeneca Plc
-
14.5.1 AstraZeneca Plc Company Details
-
14.5.2 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product and Service
-
14.6 Mabtech Limited
-
14.6.1 Mabtech Limited Company Details
-
14.6.2 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mabtech Limited Chronic Urticaria Or Hives Drug Product and Service
-
14.7 Faes Farma, SA
-
14.7.1 Faes Farma, SA Company Details
-
14.7.2 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Chronic Urticaria Or Hives Drug
-
Figure Chronic Urticaria Or Hives Drug Picture
-
Table Global Chronic Urticaria Or Hives Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chronic Urticaria Or Hives Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chronic Urticaria Or Hives Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Chronic Urticaria Or Hives Drug Consumption by Country (2017-2022)
-
Figure United States Chronic Urticaria Or Hives Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Chronic Urticaria Or Hives Drug Consumption and Growth Rate (2017-2022)
-
Figure China Chronic Urticaria Or Hives Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Chronic Urticaria Or Hives Drug Consumption and Growth Rate (2017-2022)
-
Figure India Chronic Urticaria Or Hives Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Chronic Urticaria Or Hives Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Urticaria Or Hives Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Chronic Urticaria Or Hives Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Chronic Urticaria Or Hives Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Chronic Urticaria Or Hives Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Chronic Urticaria Or Hives Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Chronic Urticaria Or Hives Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Chronic Urticaria Or Hives Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GDC-0853 Consumption and Growth Rate (2017-2022)
-
Figure Global GSK-2646264 Consumption and Growth Rate (2017-2022)
-
Figure Global BF-Derm-1 Consumption and Growth Rate (2017-2022)
-
Figure Global Bilastine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global GDC-0853 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GSK-2646264 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BF-Derm-1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bilastine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Chronic Urticaria Or Hives Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Chronic Urticaria Or Hives Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Biofrontera AG (Foundation Year, Company Profile and etc.)
-
Table Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biofrontera AG Chronic Urticaria Or Hives Drug Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product and Service
-
Table Panacea Biotec Limited (Foundation Year, Company Profile and etc.)
-
Table Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Chronic Urticaria Or Hives Drug Product and Service
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc Chronic Urticaria Or Hives Drug Product and Service
-
Table Mabtech Limited (Foundation Year, Company Profile and etc.)
-
Table Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mabtech Limited Chronic Urticaria Or Hives Drug Product and Service
-
Table Faes Farma, SA (Foundation Year, Company Profile and etc.)
-
Table Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Faes Farma, SA Chronic Urticaria Or Hives Drug Product and Service
-
